1
Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals
Condition(s):AIDS-related Dementia ComplexLast Updated:February 2, 2017Terminated
Ritonavir: 1127 Clinical Trials, Page 1 of 113
Hide Studies Not Open or Pending
2
Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China
Condition(s):HIV-1 InfectionsLast Updated:August 3, 2011Completed
3
Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.
Condition(s):Acquired Immunodeficiency SyndromeLast Updated:March 29, 2011Completed
4
A Phase 4 Study to Evaluate Pharmacokinetics and Safety of Darunavir Along With Ritonavir in Healthy Male Japanese Participants
Condition(s):HealthyLast Updated:April 10, 2013Completed
5
Microboosting of Atazanavir 300 mg With 50 mg Versus 100mg Ritonavir Daily in HIV-infected Patients: a Pharmacokinetic Study
Condition(s):HIV InfectionLast Updated:September 22, 2015Completed
6
Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB
Condition(s):Acquired Immunodeficiency Syndrome; TuberculosisLast Updated:May 11, 2017Completed
7
Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection
Condition(s):2019-nCoVLast Updated:February 10, 2020Not yet recruiting
8
Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz
Condition(s):Hyperlipidemia; HIVLast Updated:August 11, 2020Completed
9
Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition(s):HIV InfectionsLast Updated:January 13, 2010Completed
10
Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study
Condition(s):HIV InfectionsLast Updated:April 22, 2009Unknown status